EB-004

N/A

Report date: 2022/01/26 10:51:36

Base Information

Drug NameEB-004
Drug Alias NameEB-004
ClassificationCell and gene therapy > Gene therapyBiologics > Bacteriophages
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEligo Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesEligo Bioscience
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A